| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |